- Aug 15, 2018
- 605
- 346
- 63
**OLYMPIC — Northern Lifters Forum Admin**
Alright everyone, let's separate the actual appetite science from the noise that fills up fitness discussions.
You've probably heard people describe hunger as if it were a simple fuel gauge: eat enough and it switches off, eat less and it switches on. Anyone who's trained for years knows it doesn't feel that tidy. Two people can finish similar meals and describe very different levels of fullness, interest in food, or desire to keep eating.
One part of the research involves **GLP-1**, short for **glucagon-like peptide-1**. It's a hormone involved in signalling between the gut, pancreas, nervous system, and brain. This thread is about what researchers have observed when they study those signals. It isn't a product thread, a protocol, or a place for telling each other what to take.
## Hunger and fullness aren't the same measurement
Researchers usually distinguish several ideas that get lumped together in locker-room conversations:
- **Hunger:** the sensation of wanting food.
- **Satiation:** the process involved in ending a meal.
- **Satiety:** the feeling of fullness that continues after eating.
- **Food reward:** how compelling or appealing food cues feel.
- **Actual intake:** what participants eat when given an opportunity.
Those measures can move together, but not always. Someone can report low hunger while still finding a favourite food attractive. Somebody else may feel physically full but keep thinking about eating. That difference is exactly why appetite research uses more than one questionnaire or meal test.
## The early human experiment is worth knowing
In **1998**, **Flint, Raben, Astrup, and Holst** published a randomized, blinded, placebo-controlled crossover experiment in the *Journal of Clinical Investigation*. It involved **20 healthy, normal-weight men**. Investigators studied GLP-1 signalling after a standardized breakfast and then measured how much participants ate at a freely available lunch.
Under those experimental conditions, lunch energy intake was **12% lower** during the GLP-1 condition than during the saline comparison (**P = 0.002**). That's an actual measured meal difference, not a story about willpower. [1]
But keep the boundaries straight. Twenty men in a short laboratory experiment cannot tell us exactly how everyone experiences hunger across ordinary life. The study measured an acute response in a tightly defined setting. It did not establish a universal long-term outcome.
## Researchers looked across more than one experiment
**Verdich and colleagues** published a **2001 meta-analysis** in the *Journal of Clinical Endocrinology & Metabolism*. They assembled individual data from experiments totalling **115 participants** to investigate GLP-1 and freely chosen food intake. The study found variation across conditions; one reported statistical analysis associated experimental infusion rate with the size of the intake response (**r = 0.4**, **P < 0.001**). [2]
That analysis is useful because it shows both a recurring signal and the importance of experimental conditions. A meta-analysis does not magically make every study identical. It combines evidence and examines why results differ.
If someone quotes a percentage from one experiment as though it describes every person's appetite, they're skipping a few steps.
## It's not just the stomach
GLP-1 discussions often focus entirely on how long food stays in the stomach. Gastric emptying is one part of the physiology, but researchers also investigate brain circuits associated with fullness and food motivation.
In **2014**, **van Bloemendaal and colleagues** published human imaging research in *Diabetes* examining whether GLP-1 receptor activity changes responses in appetite- and reward-related brain regions. Their experimental work adds to the case that appetite regulation involves central signalling, not simply stomach volume. [3]
Brain-imaging changes are not the same as proving a person's real-world eating pattern will change permanently. Imaging measures one part of a complicated process. That's a useful distinction when a social post leaps from a colourful brain scan to a confident claim about behaviour.
## What later appetite trials measured
Two controlled studies are useful examples without turning this into a discussion of specific products.
**Blundell and colleagues (2017)** studied **30 adults with obesity** in a randomized, double-blind crossover design. In structured test-meal conditions, the active GLP-1-receptor condition was associated with a **24% lower total energy intake** across the measured freely available meals than the placebo condition. The paper also examined appetite ratings, food preference, and eating control. [4]
**Friedrichsen and colleagues (2021)** studied **72 adults with obesity** in a randomized, double-blind, parallel-group experiment lasting **20 weeks**. At the study's meal assessment, the active-condition group had **35% lower freely chosen lunch energy intake**: **1,736 kJ versus 2,676 kJ** in the placebo comparison. [5]
Those figures refer to their specific trials, participants, and test meals. They're not universal predictions, and they aren't instructions for anyone here. The study reports themselves are where questions about methods, missing data, and other outcomes belong.
## What I think people miss in these debates
First, **food intake and the feeling of hunger aren't interchangeable**. An appetite questionnaire, a brain scan, a gastric-emptying test, and a measured lunch each answer different questions. None tells the whole story by itself.
Second, **the natural hormone and an experimental receptor-targeting intervention aren't the same thing**. Their timing and biological exposure can differ. Don't transfer every result from one experiment to the other without checking what was actually tested.
Third, **individual responses vary**. The percentages above are averages from research groups. The papers do not say that all participants experienced precisely the same sensations or behaviour.
Fourth, **appetite isn't a character flaw**. Biology, learning, environment, sleep, stress, habits, and food cues interact. Saying physiology matters does not mean any one hormone explains every meal decision.
And finally, none of these studies settle every question about trained lifters, different ages, athletic performance, or what happens outside the laboratory over years. Those are separate research questions. We can discuss them honestly without inventing evidence.
For anyone who wants to check the original papers, here are the publications—not advertisements or shopping links:
1. Flint A, Raben A, Astrup A, Holst JJ. **Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.** *Journal of Clinical Investigation*. 1998. https://pubmed.ncbi.nlm.nih.gov/9449682/
2. Verdich C, et al. **A meta-analysis of the effect of glucagon-like peptide-1 (7–36) amide on ad libitum energy intake in humans.** *Journal of Clinical Endocrinology & Metabolism*. 2001. https://pubmed.ncbi.nlm.nih.gov/11549680/
3. van Bloemendaal L, et al. **GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.** *Diabetes*. 2014. https://pubmed.ncbi.nlm.nih.gov/25071023/
4. Blundell J, et al. **Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity.** *Diabetes, Obesity and Metabolism*. 2017. https://pubmed.ncbi.nlm.nih.gov/28266779/
5. Friedrichsen M, et al. **The effect of semaglutide on energy intake, appetite, control of eating, and gastric emptying in adults with obesity.** *Diabetes, Obesity and Metabolism*. 2021. https://pubmed.ncbi.nlm.nih.gov/33269530/
Three questions for the board:
1. When you talk about appetite during training, are you describing physical hunger, fullness, or how distracting food thoughts feel?
2. Which kind of evidence do you find most convincing for an appetite claim: a measured meal, a questionnaire, or a longer-term study—and why?
3. What appetite-related question in trained people would you most like researchers to investigate properly?
— OLYMPIC
Alright everyone, let's separate the actual appetite science from the noise that fills up fitness discussions.
You've probably heard people describe hunger as if it were a simple fuel gauge: eat enough and it switches off, eat less and it switches on. Anyone who's trained for years knows it doesn't feel that tidy. Two people can finish similar meals and describe very different levels of fullness, interest in food, or desire to keep eating.
One part of the research involves **GLP-1**, short for **glucagon-like peptide-1**. It's a hormone involved in signalling between the gut, pancreas, nervous system, and brain. This thread is about what researchers have observed when they study those signals. It isn't a product thread, a protocol, or a place for telling each other what to take.
## Hunger and fullness aren't the same measurement
Researchers usually distinguish several ideas that get lumped together in locker-room conversations:
- **Hunger:** the sensation of wanting food.
- **Satiation:** the process involved in ending a meal.
- **Satiety:** the feeling of fullness that continues after eating.
- **Food reward:** how compelling or appealing food cues feel.
- **Actual intake:** what participants eat when given an opportunity.
Those measures can move together, but not always. Someone can report low hunger while still finding a favourite food attractive. Somebody else may feel physically full but keep thinking about eating. That difference is exactly why appetite research uses more than one questionnaire or meal test.
## The early human experiment is worth knowing
In **1998**, **Flint, Raben, Astrup, and Holst** published a randomized, blinded, placebo-controlled crossover experiment in the *Journal of Clinical Investigation*. It involved **20 healthy, normal-weight men**. Investigators studied GLP-1 signalling after a standardized breakfast and then measured how much participants ate at a freely available lunch.
Under those experimental conditions, lunch energy intake was **12% lower** during the GLP-1 condition than during the saline comparison (**P = 0.002**). That's an actual measured meal difference, not a story about willpower. [1]
But keep the boundaries straight. Twenty men in a short laboratory experiment cannot tell us exactly how everyone experiences hunger across ordinary life. The study measured an acute response in a tightly defined setting. It did not establish a universal long-term outcome.
## Researchers looked across more than one experiment
**Verdich and colleagues** published a **2001 meta-analysis** in the *Journal of Clinical Endocrinology & Metabolism*. They assembled individual data from experiments totalling **115 participants** to investigate GLP-1 and freely chosen food intake. The study found variation across conditions; one reported statistical analysis associated experimental infusion rate with the size of the intake response (**r = 0.4**, **P < 0.001**). [2]
That analysis is useful because it shows both a recurring signal and the importance of experimental conditions. A meta-analysis does not magically make every study identical. It combines evidence and examines why results differ.
If someone quotes a percentage from one experiment as though it describes every person's appetite, they're skipping a few steps.
## It's not just the stomach
GLP-1 discussions often focus entirely on how long food stays in the stomach. Gastric emptying is one part of the physiology, but researchers also investigate brain circuits associated with fullness and food motivation.
In **2014**, **van Bloemendaal and colleagues** published human imaging research in *Diabetes* examining whether GLP-1 receptor activity changes responses in appetite- and reward-related brain regions. Their experimental work adds to the case that appetite regulation involves central signalling, not simply stomach volume. [3]
Brain-imaging changes are not the same as proving a person's real-world eating pattern will change permanently. Imaging measures one part of a complicated process. That's a useful distinction when a social post leaps from a colourful brain scan to a confident claim about behaviour.
## What later appetite trials measured
Two controlled studies are useful examples without turning this into a discussion of specific products.
**Blundell and colleagues (2017)** studied **30 adults with obesity** in a randomized, double-blind crossover design. In structured test-meal conditions, the active GLP-1-receptor condition was associated with a **24% lower total energy intake** across the measured freely available meals than the placebo condition. The paper also examined appetite ratings, food preference, and eating control. [4]
**Friedrichsen and colleagues (2021)** studied **72 adults with obesity** in a randomized, double-blind, parallel-group experiment lasting **20 weeks**. At the study's meal assessment, the active-condition group had **35% lower freely chosen lunch energy intake**: **1,736 kJ versus 2,676 kJ** in the placebo comparison. [5]
Those figures refer to their specific trials, participants, and test meals. They're not universal predictions, and they aren't instructions for anyone here. The study reports themselves are where questions about methods, missing data, and other outcomes belong.
## What I think people miss in these debates
First, **food intake and the feeling of hunger aren't interchangeable**. An appetite questionnaire, a brain scan, a gastric-emptying test, and a measured lunch each answer different questions. None tells the whole story by itself.
Second, **the natural hormone and an experimental receptor-targeting intervention aren't the same thing**. Their timing and biological exposure can differ. Don't transfer every result from one experiment to the other without checking what was actually tested.
Third, **individual responses vary**. The percentages above are averages from research groups. The papers do not say that all participants experienced precisely the same sensations or behaviour.
Fourth, **appetite isn't a character flaw**. Biology, learning, environment, sleep, stress, habits, and food cues interact. Saying physiology matters does not mean any one hormone explains every meal decision.
And finally, none of these studies settle every question about trained lifters, different ages, athletic performance, or what happens outside the laboratory over years. Those are separate research questions. We can discuss them honestly without inventing evidence.
For anyone who wants to check the original papers, here are the publications—not advertisements or shopping links:
1. Flint A, Raben A, Astrup A, Holst JJ. **Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.** *Journal of Clinical Investigation*. 1998. https://pubmed.ncbi.nlm.nih.gov/9449682/
2. Verdich C, et al. **A meta-analysis of the effect of glucagon-like peptide-1 (7–36) amide on ad libitum energy intake in humans.** *Journal of Clinical Endocrinology & Metabolism*. 2001. https://pubmed.ncbi.nlm.nih.gov/11549680/
3. van Bloemendaal L, et al. **GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.** *Diabetes*. 2014. https://pubmed.ncbi.nlm.nih.gov/25071023/
4. Blundell J, et al. **Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity.** *Diabetes, Obesity and Metabolism*. 2017. https://pubmed.ncbi.nlm.nih.gov/28266779/
5. Friedrichsen M, et al. **The effect of semaglutide on energy intake, appetite, control of eating, and gastric emptying in adults with obesity.** *Diabetes, Obesity and Metabolism*. 2021. https://pubmed.ncbi.nlm.nih.gov/33269530/
Three questions for the board:
1. When you talk about appetite during training, are you describing physical hunger, fullness, or how distracting food thoughts feel?
2. Which kind of evidence do you find most convincing for an appetite claim: a measured meal, a questionnaire, or a longer-term study—and why?
3. What appetite-related question in trained people would you most like researchers to investigate properly?
— OLYMPIC